Navigation Links
Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
Date:11/13/2009

hen is approved in approximately 80 countries, including major markets in Europe, where it is the market leader among all injectable analgesics. Approximately 90 million vials of IV acetaminophen were sold in Europe in 2008 representing an increase of approximately 13% over 2007.

The NDA for IV acetaminophen includes data from one pivotal clinical trial for the treatment of acute pain in patients following orthopedic surgery and one pivotal clinical trial for the treatment of fever. The NDA is further supported by data from a total of nine placebo-controlled clinical trials, four active-controlled clinical trials, and seven other safety or pharmacokinetic clinical trials. The submission includes safety data from over 1,400 patients who received IV acetaminophen in clinical trials, including 350 pediatric patients, from premature neonates to adolescents, and data from safety reports that collectively represent more than 53 million patient exposures to IV acetaminophen in countries outside the United States.

Conference Call and Webcast on November 13, 2009 at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time)

Cadence management will host a conference call on November 13, 2009 at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time) and interested investors may participate in the conference call by dialing 800-967-7137 (domestic) or 719-785-9446 (international). To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page. A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital s
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... CHICAGO, Ill. , Sept. 19, 2014  The ... ABBV ) declared a quarterly cash dividend of $0.42 ... payable Nov. 17, 2014 to stockholders of record at ... About AbbVie AbbVie is a global, research-based biopharmaceutical ... company,s mission is to use its expertise, dedicated people ...
(Date:9/19/2014)...  4WEB Medical announces the formal launch of the ... implants on the market today at this weekend,s ... Chicago .  The Osteotomy Truss System is ... with 74 size options included in one versatile set. ... 15 to 18 implant sizes, which limited a surgeon,s ...
(Date:9/19/2014)... Sept. 19, 2014 The American Association for ... Design and Manufacturing has joined the AAHomecare Corporate Partner ... Harvey Diamond have been actively involved in AAHomecare ... it has quickly grown into a major global manufacturer ... Drive allows AAHomecare to increase efforts on behalf of ...
Breaking Medicine Technology:4WEB Medical Unveils 3D-Printed Osteotomy Truss System 2Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2
... TriLink BioTechnologies, Inc. today announced ... Osmetech Molecular Diagnostics to supply reagents for Osmetech,s ... System and the eSensor(R) XT-8 System for Warfarin ... Osmetech with custom oligonucleotides, which are required reagents ...
... announced today that its proprietary XD(R) Technology boosts ... processes by 5-10 fold for the production of ... labs of DSM Biologics in Groningen, The Netherlands ... can be increased 5-10 fold over their previous ...
Cached Medicine Technology:TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics 2DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms 2DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms 3
(Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new blog post ... insurance plan provides for vulnerable family members. , ... a top priority for every provider. It is now ... examinations and visiting a doctor. , Life insurance ... coverage up to $300,000, but only to healthy applicants. ...
(Date:9/20/2014)... September 20, 2014 Ticket Down ... concert tickets for her 2015 “Honeymoon Tour.” This well-known ... for added savings. , In early 2015, fans will have ... the world across North America. Twenty-one-year-old Ariana Grande will hit ... will take her to 25 cities across the United States ...
(Date:9/20/2014)... Recently, Best Cheap Hosting USA (best-cheap-hosting-usa.com), ... new website. The new site provides the latest ... for customers. Here, people can find a lot ... Also, it has recommended some excellent web hosting ... the great web hosting suppliers, InMotion ( http://www.best-cheap-hosting-usa.com/go/InMotion/ ...
(Date:9/20/2014)... Recently, UWDress.com, an innovative company that provides many ... has launched a special offer for its brand new ... among worldwide clients. Now, all the company’s new and ... on its website. , Additionally, the firm also offers ... Great custom made items can be ordered at its ...
(Date:9/20/2014)... 2014 RBSEO Services, which has occupied ... has announced it provides an affordable website SEO (Search ... This announcement would benefit those new and old businesses ... cannot afford to pay a big amount for their ... their websites in top search results for their business ...
Breaking Medicine News(10 mins):Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2Health News:RBSEO Services Announces Affordable Website SEO Service at Only $175 2
... treat at all , , FRIDAY, March 6 (HealthDay News) -- ... complications in women, a European study finds. , Doctors use ... In this way, they gain time to allow steroids to ... mother to be transferred to a medical facility with a ...
... DENVER, March 6 Muscle Pharm is proud to announce ... be the exclusive Nutritional Supplement Sponsor of Shane Carwin."We are ... an absolute Freak, and a true specimen," said Brad Pyatt, ... the UFC, and is headed into his biggest professional fight ...
... Pharmaceuticals (NYSE: VRX ) today announced that its ... 2009 at 9:00 a.m. Eastern Time, at the Hilton Hotel ... Jersey 07078. The record date for stockholders entitled to ... Valeant , Valeant Pharmaceuticals International (NYSE: VRX ) ...
... Forest Laboratories, Inc. (NYSE: FRX ) and Cypress ... they expect to ship Savella(TM) (milnacipran HCl), a selective serotonin ... wholesalers and pharmacies by mid 2009. Savella was approved ... January 14, 2009 and was originally expected to be available ...
... FRANCISCO, Calif., March 6 Rigel Pharmaceuticals, Inc. ... Ryan Maynard, the company,s vice president and chief ... overview at the Barclays Capital Healthcare Conference in ... p.m. EDT.(Logo: http://www.newscom.com/cgi-bin/prnh/20030226/RIGLLOGO )To access the ...
... Endocare, Inc. (Nasdaq: ENDO ), an ... minimally invasive technologies used by urologists and interventional radiologists ... the fourth quarter and year ended December 31, 2008. ... in revenue compared to the fourth quarter of 2007 ...
Cached Medicine News:Health News:Safety of Labor-Delaying Drugs Questioned 2Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 2Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 3Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 4Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 5Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 6Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 2Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 3Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 4Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 5Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 6Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 7Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 8Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 9Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 10Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 11
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: